Related references
Note: Only part of the references are listed.Efferocytosis in health and disease
Amanda C. Doran et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Hepatic Glucagon Signaling Regulates PCSK9 and Low-Density Lipoprotein Cholesterol
Stefano Spolitu et al.
CIRCULATION RESEARCH (2019)
Protecting the heart through MK2 modulation, toward a role in diabetic cardiomyopathy and lipid metabolism
Matthieu Ruiz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
MK2 contributes to tumor progression by promoting M2 macrophage polarization and tumor angiogenesis
Lucia Suarez-Lopez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
CAMKIIγ suppresses an efferocytosis pathway in macrophages and promotes atherosclerotic plaque necrosis
Amanda C. Doran et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
The cardiovascular safety trials of DPP-4 inhibitors, GLP-1 agonists, and SGLT2 inhibitors
Matthew H. Secrest et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2017)
Genetic compensation: A phenomenon in search of mechanisms
Mohamed A. El-Brolosy et al.
PLOS GENETICS (2017)
MK2 Deletion in Mice Prevents Diabetes-Induced Perturbations in Lipid Metabolism and Cardiac Dysfunction
Matthieu Ruiz et al.
DIABETES (2016)
Targeting Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAPK2, MK2): Medicinal Chemistry Efforts To Lead Small Molecule Inhibitors to Clinical Trials
Mario Fiore et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Clinical Update: Cardiovascular Disease in Diabetes Mellitus Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations
Cecilia C. Low Wang et al.
CIRCULATION (2016)
An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques
Gabrielle Fredman et al.
NATURE COMMUNICATIONS (2016)
Hepatocyte DACH1 Is Increased in Obesity via Nuclear Exclusion of HDAC4 and Promotes Hepatic Insulin Resistance
Lale Ozcan et al.
CELL REPORTS (2016)
Treatment of Obese Insulin-Resistant Mice With an Allosteric MAPKAPK2/3 Inhibitor Lowers Blood Glucose and Improves Insulin Sensitivity
Lale Ozcan et al.
DIABETES (2015)
A p38MAPK/MK2 signaling pathway leading to redox stress, cell death and ischemia/reperfusion injury
Muhammad Imtiaz Ashraf et al.
CELL COMMUNICATION AND SIGNALING (2014)
Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated kinase pathway
Gabrielle Fredman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?
Iciar Martin-Timon et al.
WORLD JOURNAL OF DIABETES (2014)
Activation of Calcium/Calmodulin- Dependent Protein Kinase II in Obesity Mediates Suppression of Hepatic Insulin Signaling
Lale Ozcan et al.
CELL METABOLISM (2013)
Homology modeling and ligand docking of Mitogen-activated protein kinase-activated protein kinase 5 (MK5)
Inger Lindin et al.
THEORETICAL BIOLOGY AND MEDICAL MODELLING (2013)
Calcium Signaling through CaMKII Regulates Hepatic Glucose Production in Fasting and Obesity
Lale Ozcan et al.
CELL METABOLISM (2012)
Insulin Resistance, Hyperglycemia, and Atherosclerosis
Karin E. Bornfeldt et al.
CELL METABOLISM (2011)
Distinct Functions of the Mitogen-activated Protein Kinase-activated Protein (MAPKAP) Kinases MK2 and MK3 MK2 MEDIATES LIPOPOLYSACCHARIDE-INDUCED SIGNAL TRANSDUCERS AND ACTIVATORS OF TRANSCRIPTION 3 (STAT3) ACTIVATION BY PREVENTING NEGATIVE REGULATORY EFFECTS OF MK3
Christian Ehlting et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Concept of Vulnerable/Unstable Plaque
Aloke V. Finn et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
MAPK-Activated Protein Kinase-2 in Cardiac Hypertrophy and Cyclooxygenase-2 Regulation in Heart
John M. Streicher et al.
CIRCULATION RESEARCH (2010)
Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of Apoe-/- mice
Edward Thorp et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Insulin Resistance and Atherosclerosis
Babak Razani et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2008)
Systemic deficiency of the MAP kinase-activated protein kinase 2 reduces atherosclerosis in hypercholesterolemic mice
Kumaravelu Jagavelu et al.
CIRCULATION RESEARCH (2007)
The mitogen-activated protein kinase (MAPK)-activated protein kinases MK2 and MK3 cooperate in stimulation of tumor necrosis factor biosynthesis and stabilization of p38 MAPK
N. Ronkina et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
MAPKAP kinases - MKs - two's company, three's a crowd
M Gaestel
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Arachidonic acid promotes phosphorylation of 5-lipoxygenase at Ser-271 by MAPK-activated protein kinase 2 (MK2)
O Werz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
